Improved quality of life in Norwegian heart failure patients after follow-up in outpatient heart failure clinics: Results from the Norwegian heart failure registry

European Journal of Heart Failure

Volumn 12, Issue 11, 2010, Pages 1247-1252

  Hole, Torstein ^a,b   Grundtvig, Morten ^c   Gullestad, Lars ^d   Flønæs, Berit ^e   Westheim, Arne ^f  

^a Sunnmøre Hospital Trust   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c INNLANDET HOSPITAL TRUST   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e VESTRE VIKEN HOSPITAL TRUST   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Disease management; Heart failure; Quality of life

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

AGED; ARTICLE; COMORBIDITY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; CONTINUITY OF PATIENT CARE; DISEASE MANAGEMENT; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NORWAY; OUTPATIENT CLINICS, HOSPITAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; REGISTRIES;

EID: 77958601363     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq156     Document Type: Article

References (25)

1. McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004;44:810-819.
2. Roccaforte R, Demers C, Baldassarre F, Teo KK, Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 2005;7:1133-1144.
3. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989
4. Hobbs FDR, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur Heart J 2002; 23:1867-1876.
5. Cline CMJ, Willenheimer RB, Erhardt LR, Wiklund I, Israelsson BYA. Health-related qualityoflifeinelderly patients with heart failure. Scand CardiovascJ1999;33:278-285.
6. Doba N, Tomiyama H, Nakayama T. Drugs, heart failure and quality of life: What are we achieving? What should we be trying to achieve? Drugs Aging 1999;14:153-163.
7. Krumholz HM, baker DW, Ashton CM, Dunbar SB, Friesinger GC, Havranek EP, Hlatky MA, Konstam M, Ordin DL, Pina IL, Pitt B, Spertus JA. Evaluating quality of care for patients with heart failure. Circulation 2000;101:122-140.
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
9. Rector TS, Kubo SH, Cohn JN. Patients self-assessment of their congestive heart failure: content, reliability and validity of a new measure, The Minnesota Living with Heart Failure questionnaire. Heart Failure 1987;Oct/Nov:198-209.
10. Morgan K, McGee H, Shelley E. Quality of life assessment in heart failure interven-tions:a 10-year (1996-2005) review. Eur J Cardiovasc Prev Rehabil 2007;14:589-607.
11. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Roecker EB, Schultz MK, DeMets DL. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-1658. (Pubitemid 32479962)
12. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353: 2001-2007.
13. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. The Euro Heart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463. (Pubitemid 36286187)
14. Fabbri G, Gorini M, Maggioni AP, Cacciatore G, Di Lenarda A. Italian Network on Congestive Heart Failure: ten-yearexperience. G Ital Cardiol (Rome) 2006;7:689-694.
15. Atienza F, Anguita M, Martinez-Alzamora N, Osca J, Ojeda S, Almenar L, Ridocci F, Vallés F, De Vallesco JA. Multicenter randomize trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail 2004;6:643-652.
16. Gwadry-Sidhar FH, Arnold JMO, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J 2005;150:982.e1-982.e.9.
17. Parnell MM, Holst DP, Kaye DM. Exercise training increases arterial compliance in patients with congestive heart failure. Clinical Science 2002;102:1-7.
18. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure. Circulation 1999;99: 1173-1182.
19. Linde C, Braunschweig F, Gadler F, Bailleul C, Daubert JC. Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: results from the MUltisite STimulation In Cardiomyopathy study (MUSTIC). Am J Cardiol 2003;91:1090-1095.
20. Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J, Misier AR, Bøcker D, Block M, Kirkels JH, Kramer A, Huvelle E. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-2116.
21. The MERIT-HF Study Group. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The meto-prolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). J Am Med Assoc 2000;283:1295-1302.
22. Cowley AJ, Wiens BL, Segal R, Rich MW, Santanello NC, Dasbach EJ, Pitt B. Randomised comparison of losartan vs. captopril on quality of life in elderly patients with symptomatic heart failure: the losartan heart failure ELITE quality of life sub-study. Qual Life Res 2000;9:377-384.
23. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne A-S. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003;107:294-299.
24. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendane. Am Heart J 1992;124:1017-1025.
25. O'Connor CM, Abraham WT, Albert NM, Clare R, Stough WD, Gheorghiade M, Greenberg GH, Yancy CW, Young JB, Fonarow GC. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 2008;156:662-673.